
The UK’s competition authority dismissed concerns that a merger of mobile operator O2 and fixed operator Virgin Media would have negative implications on wholesale services, provisionally clearing the proposed deal without conditions, reported the BBC.
In a statement, the Competition and Markets Authority (CMA) said its investigation concluded the combination of the businesses was unlikely to have a negative effect on either fixed or mobile wholesale markets.
Both Virgin and O2 provide some wholesale services to other mobile network operators in the UK, as well as retail services to consumers. The CMA noted that its investigation focused on whether the merger could lead to reduced competition in wholesale services as part of the review.
Virgin provides wholesale leased lines to mobile telecommunications companies, such as Vodafone and Three, which they use to connect key parts of their network. Similarly, O2 offers mobile operators such as Sky and Lycamobile, which do not have their own mobile network, use of the O2 network to provide their customers with mobile phone services.
The CMA stated that it was initially concerned that, following the merger, Virgin and O2 could raise prices or reduce the quality of these wholesale services. Having examined the evidence, the CMA has now provisionally concluded that the proposed merger is unlikely to lead to any substantial lessening of competition in relation to the supply of wholesale services.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas